| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 9,186 | $4.87 | $44,745.01 | -0.5% | -61.7% | -72.3% | |
| Mar 4, 2024 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 2,968 | $4.87 | $14,457.13 | -1.3% | -61.7% | -72.3% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Day Mark J.57 | Chief Technology Officer | Sell | 3,248 | $111.14 | $360,982.72 | -5.0% | -22.9% | -1.6% | |
| Mar 4, 2024 | PRCT Procept Biorobotics Corp | Krummel Thomas M69 | Director | Sell | 20,000 | $48.53 | $970,642.70 | -12.5% | +37.0% | +35.8% | |
| Mar 4, 2024 | MMSI Merit Medical Systems Inc | Evans Stephen C.64 | Director | Sell | 1,000 | $76.35 | $76,348.00 | -12.2% | +7.4% | +33.2% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Blackford Quentin S.60 | President And CEO | Sell | 4,221 | $111.14 | $469,121.94 | -2.3% | -22.9% | -1.6% | |
| Mar 4, 2024 | BRKR Bruker Corp | Requardt Hermann Fritz | Director | Sell | 15,000 | $90.06 | $1,350,898.28 | -24.0% | -28.4% | -48.5% | |
| Mar 4, 2024 | IRTC Irhythm Holdings, Inc. | Shrishrimal Sumi60 | EVP, Chief Risk Officer | Sell | 723 | $111.14 | $80,354.22 | -2.9% | -22.9% | -1.6% | |
| Mar 4, 2024 | NVCR Novocure Ltd | Leonard Frank X76 | EVP, Pres., Novocure Oncology | Sell | 2,519 | $16.02 | $40,357.57 | -0.8% | +45.4% | +10.7% | |
| Mar 4, 2024 | NVCR Novocure Ltd | Groenhuysen Wilhelmus Cm65 | Chief Operating Officer | Sell | 3,324 | $16.02 | $53,252.85 | -0.7% | +45.4% | +10.7% | |
| Mar 4, 2024 | LMAT Lemaitre Vascular Inc | Lemaitre George W54 | Chairman And CEO | Sell | 101,478 | $68.43 | $6,944,096.70 | -0.6% | +15.7% | +33.2% | |
| Mar 1, 2024 | RXST Rxsight, Inc. | Thunen Shelley B74 | Chief Financial Officer | Sell | 10,000 | $56.37 | $563,725.65 | -16.0% | +6.9% | -49.1% | |
| Mar 1, 2024 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 6,954 | $9.06 | $63,003.24 | -0.2% | -21.5% | -7.3% | |
| Mar 1, 2024 | Huller Kelly58 | SVP, GC, Corporate Secretary | Sell | 7,500 | $54.10 | $405,730.10 | -70.7% | +22.3% | +47.5% | ||
| Mar 1, 2024 | NXGL Nexgel, Inc. | Drapczuk Adam E III62 | Chief Financial Officer | Buy | 47,394 | $2.11 | $100,001.34 | New | -14.7% | +28.4% | |
| Mar 1, 2024 | BAX Baxter International Inc | Mason Jeanne K69 | EVP, Chief Hr Officer | Sell | 64,488 | $40.61 | $2,618,857.68 | -31.2% | -18.5% | -15.8% | |
| Mar 1, 2024 | ARAY Accuray Inc | Hoge Michael68 | Senior VP Global Operations | Sell | 11,991 | $2.59 | $31,056.69 | -3.0% | -39.8% | -23.0% | |
| Mar 1, 2024 | ATEC Alphatec Holdings, Inc. | Koning John Todd57 | Chief Financial Officer | Sell | 121,601 | $13.30 | $1,617,293.30 | -22.0% | -24.5% | -6.6% | |
| Mar 1, 2024 | NXGL Nexgel, Inc. | Glassman Steven Mark48 | Director | Buy | 11,848 | $2.11 | $24,999.28 | +9.6% | -14.7% | +28.4% | |
| Mar 1, 2024 | ELMD Electromed, Inc. | Cunniff James L. | CEO And President | Buy | 9,000 | $15.25 | $137,250.00 | +900.0% | -3.6% | +76.2% | |
| Mar 1, 2024 | PEN Penumbra Inc | Kassing Don W.49 | Director | Sell | 778 | $234.72 | $182,612.16 | -36.6% | -20.6% | +20.6% | |
| Mar 1, 2024 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 6,983 | $66.35 | $463,322.05 | -11.5% | +11.7% | +54.6% | |
| Mar 1, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 10,000 | $82.99 | $829,891.92 | -6.3% | +64.9% | -7.7% | |
| Mar 1, 2024 | TMDX Transmedics Group, Inc. | Tobin James R60 | Director | Sell | 13,380 | $83.63 | $1,118,954.54 | -1.2% | +64.9% | -7.7% | |
| Mar 1, 2024 | INSP Inspire Medical Systems, Inc. | Griffin Jerry C84 | Director | Sell | 554 | $179.44 | $99,409.76 | -3.0% | -15.9% | +1.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.